When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
BOLT - Bolt Biotherapeutics EPS beats by $0.02 beats on revenue
Bolt Biotherapeutics Inc.
Bolt Biotherapeutics (NASDAQ:BOLT): Q3 GAAP EPS of -$0.63 beats by $0.02. Revenue of $0.8M beats by $0.3M. Press Release Cash, cash equivalents, and marketable securities were $290.5M as of September 30, 2021, compared to $310.9M as of June 30, 2021. Bolt Biotherapeutics expects this cash balance to fund operations through the end of 2023.